Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2025-05-13 00:00:00 ET · period of report 2025-05-12 · accession 0001773751-25-000162 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-13 | 2025-05-12 | HIMS | Baird Melissa | COO | S - Sale+OE | $56.02 | -33.3K | 817.8K | -4% | -$1.87M |
| D | 2025-05-13 | 2025-05-12 | HIMS | Baird Melissa | COO | M - OptEx | $2.43 | +33.3K | 838.4K | +4% | +$81.0K |
| D | 2025-05-13 | 2025-05-12 | HIMS | Baird Melissa | COO | M - OptEx | $0.00 | -33.3K | 693.8K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-05-12 | S | D | 5,190 | $57.87 | 805,083 | D | — | — | (F5) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Class A Common Stock | 2025-05-12 | S | D | 7,556 | $56.80 | 810,273 | D | — | — | (F4) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Class A Common Stock | 2025-05-12 | M | A | 33,333 | $2.43 | 838,416 | D | — | — | |
| 4 | Common | Class A Common Stock | 2025-05-12 | S | D | 13,786 | $54.98 | 824,630 | D | — | — | (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Class A Common Stock | 2025-05-12 | S | D | 6,801 | $55.86 | 817,829 | D | — | — | (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 6 | Derivative | Stock Option (right to buy) | 2025-05-12 | M | D | 33,333 | $0.00 | 693,795 | D | $2.43 · — to 2030-05-13 | 33,333 Class A Common Stock | (F6) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested. |